Related Experiment Video
Updated: May 17, 2026

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice
Published on: July 8, 2020
Rituximab followed by mycophenolate mofetil in children with IgM nephropathy
Jin'ai Gu1, Yonghui Xia, Jianhua Mao
1Department of Nephrology, The Childrens Hospital of Zhejiang University School of Medicine, Hangzhou 310003, China.
Abstract:
IgM nephropathy presents with refractory nephrotic syndrome and its treatment is a significant challenge for pediatricians. We present two patients with IgM nephropathy and frequently relapsing nephrotic syndrome treated with rituximab and subsequently mycophenolate mofetil. Both showed complete remission, which 24 to 30 months later, was still maintained. The role of mycophenolate mofetil therapy in maintaining remission after successful treatment of rituximab in IgM nephropathy needs to be examined.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Kidney Transplant II: Surgical Procedure
Chronic Kidney Disease III: Interprofessional Care
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF